Multimeric Gets Innovation Grant

6/25/10Follow @bvbigelow

The National Institute on Drug Abuse has awarded an innovation grant worth $350,000 over two years to San Diego’s Multimeric Biotherapeutics to develop a vaccine against nicotine, and eventually other drugs of abuse. Multimeric says vaccines against nicotine are designed to generate antibodies that sequester nicotine in the blood and prevent the molecules from crossing into the brain and re-enforcing the nicotine habit. As I reported in October, the two-year-old biotech is developing proprietary methods for boosting highly targeted antibody responses.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at or call (619) 669-8788 Follow @bvbigelow

By posting a comment, you agree to our terms and conditions.